Instalab
logoInstalab

Mustard (Sin a 1) IgE

Blood Test
Pinpoint whether mustard is the hidden trigger behind your unexplained allergic reactions.
4.9 (4,697 reviews)
Tested by Diagnostic Solutions Lab
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a Mustard (Sin a 1) IgE test?

This test is most useful if any of these apply to you.

Reacting to Foods You Cannot Identify
You have had hives, swelling, or stomach symptoms after eating, but cannot figure out what triggered them. This test checks one common hidden culprit.
Already Diagnosed With Other Seed Allergies
You know you react to nuts, sesame, or other seeds, and want to clarify whether mustard sensitization is part of your picture or cross-reactivity.
Managing Atopic Dermatitis or Asthma
Your skin or airway disease is severe and you want a more precise map of which food proteins your immune system is reacting to.
Had a Reaction You Cannot Explain
You had an unexplained allergic reaction and your standard food panel was negative. A component-level mustard test may catch what extract testing misses.

About Mustard (Sin a 1) IgE

Mustard is a common but often overlooked food allergen, hiding in salad dressings, marinades, sauces, and processed meats. If you have had a reaction after eating something and cannot pin down the cause, knowing whether your immune system is primed to react to a specific mustard seed protein can sharpen your answer.

This test looks for IgE (immunoglobulin E) antibodies in your blood that specifically target Sin a 1, a major protein from yellow mustard seeds. A positive result means your immune system has learned to recognize this single protein as a threat, which is different from a generic mustard extract test that mixes many proteins together.

What This Test Actually Measures

IgE is one type of antibody your body produces. It is made by a class of white blood cells (B cells) that have shifted into an allergy-fighting mode and matured into antibody-producing factories. These cells live mainly in your lymph nodes and the linings of your gut and airways, not floating freely in the blood, so the IgE you can measure in serum is a small window into a larger process.

When you become sensitized to mustard, your body produces IgE shaped specifically to lock onto Sin a 1, one of the main allergenic proteins in yellow mustard seeds. These antibodies attach to mast cells and basophils, the immune cells that release histamine and other chemicals during an allergic reaction. The next time you eat mustard, those cells can fire off the cascade that produces hives, swelling, gut symptoms, or in severe cases, anaphylaxis.

This is a research-grade marker. It is a real and well-characterized allergen test, but published research on Sin a 1 specifically is thin compared with peanut, milk, or egg components. There are no standardized cutoffs or population-wide thresholds that tell you a single number means severe allergy versus mild sensitization. The result is most useful when paired with your symptom history and broader allergy workup.

Sensitization Versus True Allergy

Having detectable IgE to Sin a 1 means your immune system has been sensitized to mustard. It does not, on its own, mean you will react when you eat it. Across food allergy research, many people show positive IgE to food proteins without ever having symptoms, especially those with atopic dermatitis. The clinical meaning of a positive Sin a 1 result depends on whether you have had reactions consistent with mustard exposure.

This is one of the most important ideas to grasp before testing. A positive Sin a 1 result in someone who eats mustard regularly without trouble has a very different meaning than the same result in someone who had hives after a sandwich with honey mustard.

Food Allergy and Risk of Anaphylaxis

IgE-mediated food allergy is the main condition this test is used to investigate. When mustard IgE binds Sin a 1 on the surface of mast cells, exposure to mustard can trigger immediate symptoms such as itching, hives, swelling of the lips or throat, vomiting, wheezing, or full anaphylaxis. Sin a 1 is specifically a 2S albumin, a subtype of seed storage protein. The 2S albumin family is resistant to heat and digestion and is generally associated with more clinically meaningful, sometimes severe reactions across many seed and nut allergens.

In a study of 100 adults with atopic dermatitis, higher levels of specific IgE to food and inhalant components were linked to more severe disease, more frequent asthma, and more frequent allergic rhinitis. This is not Sin a 1 specifically, but it illustrates the broader pattern: stronger sensitization tends to track with more clinical disease.

Asthma and Allergic Rhinitis

Patterns of IgE sensitization to multiple allergens are tied to asthma and rhinitis. Research has shown that the structure of someone's IgE response across many allergens predicts asthma severity, with denser webs of sensitization seen in more severe disease. A Sin a 1 result alone does not predict asthma risk, but it adds one more piece to your broader sensitization picture.

Atopic Dermatitis

In the same 100-patient study of adults with atopic dermatitis, high specific IgE levels to multiple components were associated with worse skin disease and with the presence of asthma and rhinitis as comorbidities. Sin a 1 was not singled out, but mustard is part of the broader food-component panel that some patients with severe atopic dermatitis are sensitized to.

Cross-Reactivity Adds Nuance

Mustard seeds contain several allergenic proteins beyond Sin a 1. Sin a 1 is a 2S albumin, and the 2S albumin family shows cross-reactivity among seeds and nuts (including peanut, tree nuts, and sesame). A different mustard protein, Sin a 2, is an 11S globulin (a different storage-protein superfamily) and shows its own pattern of cross-reactivity with homologous 11S globulins in tree nuts and peanut. Because Sin a 1 and Sin a 2 belong to different protein families, the cross-reactivity drivers can differ. Component-level testing like Sin a 1 helps separate primary mustard allergy from cross-reactivity more cleanly than generic mustard extract.

What This Test Reveals That Standard Panels Miss

Standard allergy panels typically measure IgE to whole mustard extract, which is a mix of many proteins. That approach can flag sensitization but cannot tell you which specific protein your immune system is reacting to. Component-resolved tests like Sin a 1 sharpen the picture. Across food allergy research, component IgE tests for storage proteins tend to be highly specific, meaning a positive result is more likely to reflect clinically meaningful allergy than a positive extract test.

For peanut, component tests like Ara h 2 have shown high diagnostic accuracy in published research. The exact numbers for Sin a 1 have not been reported with the same depth, but the diagnostic logic is the same: a positive component result strengthens the case that mustard is a real allergen for you, while a negative result on the component but positive on the extract may point toward cross-reactivity rather than primary mustard allergy.

Why One Reading Is Not Enough

Specific IgE levels are not static. They can drift with new exposures, evolving sensitization, immune system changes during illness, and over years as some food allergies are outgrown while others appear. A single result tells you what your immune system looks like today. It does not tell you the trajectory, and that trajectory often matters more for decisions.

Get a baseline now if you are investigating possible mustard allergy. If your level is detectable, retest in 6 to 12 months to see whether it is rising, falling, or stable. If you have started avoiding mustard, declining levels over a year or two can be one piece of evidence (combined with supervised challenge if appropriate) that your sensitization may be fading. If you have had a clear reaction, your management does not change based on the number alone, but tracking helps you and your allergist make better decisions over time.

When Results Can Be Misleading

A few situations can make a single Sin a 1 IgE result harder to interpret correctly:

  • Sensitization without symptoms: detectable IgE means your immune system recognizes Sin a 1, but it does not by itself mean you will react. Many people carry food-specific IgE without clinical allergy.
  • Cross-reactivity confusion: if you are tested with a generic mustard extract, a positive result might actually reflect IgE to a related protein in tree nuts or peanut rather than mustard itself. The Sin a 1 component test reduces this ambiguity but does not erase it.
  • Negative does not equal safe if symptoms persist: mustard contains multiple allergenic proteins. A negative Sin a 1 result with a convincing reaction history may mean you are reacting to a different mustard protein, and broader testing is warranted.
  • Recent severe reactions: standard practice is to wait several weeks after a major allergic reaction before testing or retesting, since skin testing in particular is less reliable during the immediate post-reaction period. Spacing the blood draw a few weeks after the event gives a more representative picture alongside your history.

Reading an Unexpected Result

If your Sin a 1 IgE comes back positive and you have had reactions consistent with mustard exposure, your next step is a conversation with an allergist about confirming the diagnosis, building an avoidance plan, and carrying epinephrine if your reaction history warrants it. A supervised oral food challenge remains the gold standard for confirming or ruling out clinical allergy when the picture is unclear.

If the result is positive but you have never reacted to mustard, do not panic and start strict avoidance based on the number alone. Sensitization without symptoms is common. Bring the result to an allergist who can integrate it with skin prick testing, your full history, and possibly a controlled challenge. If the result is negative but you still suspect mustard, ask about testing for other mustard components or seeking specialist evaluation, because Sin a 1 is one important protein among several.

What Moves This Biomarker

Evidence-backed interventions that affect your Mustard (Sin a 1) IgE level

Decrease
Anti-IgE monoclonal antibody therapy (omalizumab)
Anti-IgE biologics like omalizumab bind free IgE in your blood and stop it from triggering mast cells, raising the amount of allergen you can tolerate before a reaction. In the OUtMATCH randomized trial of peanut-allergic patients, 67% of those treated with omalizumab tolerated at least 600 mg of peanut protein on supervised food challenge, compared with 7% on placebo. Omalizumab is now FDA-approved for IgE-mediated food allergy. The therapy has been studied primarily for peanut allergy, not mustard, so direct effects on Sin a 1 IgE specifically have not been quantified, but the mechanism applies to all IgE-driven food allergies.
MedicationStrong Evidence
Decrease
Allergen-specific immunotherapy combined with anti-IgE therapy
Combining oral immunotherapy with anti-IgE biologics can desensitize your immune system to a food allergen while the antibody dampens reactions during the build-up phase. Research has shown this combination improves desensitization outcomes in food allergy, though it has been studied primarily in peanut allergy. Mustard-specific immunotherapy protocols are not yet a standard offering, so applicability to Sin a 1 is mechanistic rather than directly proven. The measured Sin a 1 IgE number can be biphasic in immunotherapy: IgE often rises in the first weeks before declining over months to years, while protective IgG4 antibodies rise.
MedicationModerate Evidence

Frequently Asked Questions

References

10 studies
  1. M. Michelet, B. Balbino, L. Guilleminault, L. ReberEuropean Journal of Immunology2021
  2. I. Ogulur, Y. Pat, O. Ardicli, E. Barletta, L. Cevhertas, R. Fernández-santamaría, M. Huang, M. Bel Imam, J. Koch, S. Ma, D. Maurer, Y. Mitamura, Y. Peng, U. Radzikowska, a. Rinaldi, J. Rodríguez-coira, P. Satitsuksanoa, S. Schneider, a. Wallimann, D. Zhakparov, R. Ziadlou, M. Brüggen, W. Van De Veen, M. Sokolowska, K. Baerenfaller, L. Zhang, M. Akdis, C. AkdisAllergy2021
  3. A. Schoos, D. Bullens, B. Chawes, J. Costa, L. De Vlieger, a. Dunngalvin, M. Epstein, J. Garssen, C. Hilger, K. Knipping, a. Kuehn, D. Mijakoski, D. Munblit, N. Nekliudov, C. Ozdemir, K. Patient, D. Peroni, S. Stoleski, E. Stylianou, M. Tukalj, K. Verhoeckx, M. Zidarn, W. Van De VeenFrontiers in Immunology2020
  4. G. Roberts, S. Fontanella, a. Selby, R. Howard, S. Filippi, G. Hedlin, B. Nordlund, P. Howarth, S. Hashimoto, P. Brinkman, L. Fleming, C. Murray, a. Bush, U. Frey, F. Singer, a. Schoos, W. Van Aalderen, R. Djukanović, K. Chung, P. Sterk, a. CustovicThe Journal of Allergy and Clinical Immunology2020
  5. J. ČElakovská, J. Bukac, E. Cermakova, R. Vankova, H. Skalská, J. Krejsek, C. AndrysInternational Journal of Molecular Sciences2021